• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Amicus Therapeutics Inc

+ Add to Watchlist

FOLD:US

8.1800 USD 0.2400 3.02%

As of 20:10:00 ET on 12/26/2014.

Snapshot for Amicus Therapeutics Inc (FOLD)

Open: 8.0000 Day's Range: 7.9400 - 8.3000 Volume: 705,861
Previous Close: 7.9400 52wk Range: 1.7650 - 8.7900 1-Yr Rtn: +270.14%

Stock Chart for FOLD

No chart data available.
  • FOLD:US 8.1800
  • 1D
  • 1M
  • 1Y
7.9400
Interactive FOLD Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for FOLD

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.8903
Est. EPS (USD) (12/2014) -0.8700
Est. PEG Ratio -
Market Cap (M USD) 778.61
Shares Outstanding (M) 95.19
30 Day Average Volume 2,310,161
Price/Book (mrq) 14.9809
Price/Sale (ttm) 346.0990
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/03/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for FOLD

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for FOLD

Amicus Therapeutics, Inc. is a biopharmaceutical company that develops orally-administered, small molecule drugs to treat human genetic diseases. The drugs, called pharmacological chaperones, are being developed to treat Fabray, Gaucher, and Pompe disease.

John F CrowleyChairman/CEOWilliam D Baird III "Chip"Chief Financial Officer
Bradley L CampbellChief Operating OfficerJay BarthChief Medical Ofcr
More Company Profile & Key Executives for FOLD

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil